Lipocine Company Leadership
| LPCN Stock | USD 4.80 0.27 5.33% |
Lipocine employs about 17 people. The company is managed by 12 executives with a total tenure of roughly 69 years, averaging almost 5.0 years of service per executive, having 1.42 employees per reported executive. Analysis of Lipocine's management performance can provide insight into the firm performance.
| Mahesh Patel Chairman Co-Founder, Chairman, CEO and Pres |
| Gregory Bass President Executive Vice President Chief Commercial Officer |
Lipocine |
Lipocine's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Lipocine's future performance. Based on our forecasts, it is anticipated that Lipocine will maintain a workforce of about 17 employees by May 2024.Lipocine Management Team Effectiveness
The company has return on total asset (ROA) of (0.3702) % which means that it has lost $0.3702 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.584) %, meaning that it created substantial loss on money invested by shareholders. Lipocine's management efficiency ratios could be used to measure how well Lipocine manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of April 2024, Return On Tangible Assets is likely to drop to -0.75. In addition to that, Return On Capital Employed is likely to grow to -0.7. At this time, Lipocine's Total Assets are very stable compared to the past year. As of the 24th of April 2024, Other Assets is likely to grow to about 4 M, while Net Tangible Assets are likely to drop about 27 M.As of the 24th of April 2024, Common Stock Shares Outstanding is likely to grow to about 5.5 M, while Net Loss is likely to drop (13 M).
Lipocine Workforce Comparison
Lipocine is rated fourth overall in number of employees category among related companies. The total workforce of Health Care industry is now estimated at about 7,337. Lipocine adds roughly 17.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Lipocine Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Lipocine insiders, such as employees or executives, is commonly permitted as long as it does not rely on Lipocine's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Lipocine insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2022-12-01 | 5.0 | 5 | 1 | 426,089 | 46,000 |
| 2021-12-01 | 3.0 | 3 | 1 | 326,000 | 46,000 |
| 2021-03-01 | 1.0 | 1 | 1 | 275,000 | 26,000 |
| 2020-12-01 | 1.6364 | 18 | 11 | 1,121,732 | 762,119 |
| 2019-12-01 | 2.1667 | 13 | 6 | 536,232 | 283,250 |
| 2017-12-01 | 0.6667 | 10 | 15 | 341,125 | 129,251 |
| 2017-03-01 | 7.0 | 7 | 1 | 142,000 | 55,000 |
| 2015-06-01 | 6.0 | 6 | 1 | 170,000 | 0.00 |
| 2014-03-01 | 1.0 | 3 | 3 | 30,000 | 0.00 |
| 2013-09-01 | 0.1176 | 2 | 17 | 62,000 | 211,330 |
Lipocine Notable Stakeholders
A Lipocine stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Lipocine often face trade-offs trying to please all of them. Lipocine's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Lipocine's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Mahesh Patel | Co-Founder, Chairman, CEO and Pres | Profile | |
| Gregory Bass | Executive Vice President Chief Commercial Officer | Profile | |
| Morgan Brown | CFO, Executive Vice President | Profile | |
| Richard Ono | Director | Profile | |
| Jeffrey Fink | Director | Profile | |
| Stephen Hill | Lead Independent Director | Profile | |
| John Higuchi | Non-Executive Director | Profile | |
| CPA CPA | Co Sec | Profile | |
| Logan Morse | Marketing Sales | Profile | |
| Nachiappan Chidambaram | Senior Development | Profile | |
| M MD | Chief Director | Profile | |
| Krista Fogarty | Principal Controller | Profile |
About Lipocine Management Performance
The success or failure of an entity such as Lipocine often depends on how effective the management is. Lipocine management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Lipocine management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Lipocine management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.71) | (0.75) | |
| Return On Capital Employed | (0.73) | (0.70) | |
| Return On Assets | (0.71) | (0.75) | |
| Return On Equity | (0.80) | (0.76) |
The data published in Lipocine's official financial statements usually reflect Lipocine's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Lipocine. For example, before you start analyzing numbers published by Lipocine accountants, it's critical to develop an understanding of what Lipocine's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Lipocine's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lipocine's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Lipocine's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lipocine. Please utilize our Beneish M Score to check the likelihood of Lipocine's management manipulating its earnings.
Lipocine Workforce Analysis
Traditionally, organizations such as Lipocine use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Lipocine within its industry.Lipocine Manpower Efficiency
Return on Lipocine Manpower
| Revenue Per Employee | 6.5K | |
| Revenue Per Executive | 9.2K | |
| Net Loss Per Employee | 961.9K | |
| Net Loss Per Executive | 1.4M | |
| Working Capital Per Employee | 1.2M | |
| Working Capital Per Executive | 1.7M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Lipocine Stock analysis
When running Lipocine's price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.14) | Revenue Per Share (0.54) | Quarterly Revenue Growth (1.00) | Return On Assets (0.37) | Return On Equity (0.58) |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.